|
The record date for the said dividend payout is 17 October 2023. The interim dividend will be paid to such shareholders on or after 23 October 2023.
With a total equity base of 12,25,27,172 shares (as on 30 June 2023), this translates to a dividend payout of Rs 275.68 crore.
Glenmark Life Sciences is a developer and manufacturer of select high-value, non-commoditised active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes.
The company's consolidated net profit jumped 24.57% to Rs 135.45 crore in Q1 FY24 as compared with Rs 108.73 crore posted in corresponding quarter last year. Revenue from operations increased 18.08% to Rs 578.45 crore in Q1 FY24 as compared with 489.87 crore in Q1 FY23.
|